Opportunities from the Agricultural Transition: Bayer, Sumitomo, and MustGrow Biologics
Conventional agriculture must rethink its approach: Chemical pesticides are to be reduced and replaced with biological alternatives. Strict regulations, such as the European Union's…
Lahontan Gold Debunks Industry Myths and Advances Toward Gold Production with Limited Dilution
Most gold developers on the TSX Venture Exchange follow a dismal pattern: lots of talk, little substance, and endless dilution. Things are different at…
Volatus Aerospace on the Rise – From Aerial Imagery to a Question of Power: Drone Technology Is Shaping the Future
The skies no longer belong solely to airplanes. Drones are rapidly evolving from niche tools into a core technology across industries. They are man-made,…
BP, Globex Mining, Rio Tinto: The Winners of the 2026 Commodities Boom
The global commodities landscape is undergoing a fundamental transformation. Oil remains important, but the strategic focus is shifting toward the metals and minerals that…
Boost from the Energy Shock: A.H.T. Syngas With a 150% Chance, Nordex Due for a Correction, and What is Happening with Verbio?
The energy and oil price shock is hitting global markets and simultaneously marking a turning point for investors. Skyrocketing prices for fossil fuels, wars,…
One of the best silver intercepts in the world year to date
Group Eleven Resources reports one of the strongest silver intercepts globally this year. CEO Bart Jaworski discusses drilling, jurisdiction advantages and exploration plans in…
Globex Mining takes a very different approach to mineral exploration and development
In this Capital Compass episode, Globex Mining discusses its diversified exploration strategy, portfolio of over 200 assets, royalty exposure, and opportunities in gold and…
A project generator designed to limit dilution, share risk, and create opportunities
Avrupa Minerals discusses its project generator model, copper-zinc exploration in Finland and Portugal, joint ventures, and plans to limit dilution while advancing multiple assets.
Developing a neurosciences platform with potential applications across several indications
In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…
Market Open: Allbirds Explodes on AI Pivot, Rogers Expands Satellite Reach | Apr 16th
TSX edges higher as Allbirds explodes on an AI pivot, Stellantis partners with Microsoft, Rogers expands satellite service, oil rises and gold rebounds.